Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A BALL

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Biochemistry|November 26, 1990
Metabolism of cysteinyl leukotrienes in monkey and manM Huber, J Müller, I Leier, et al.
British Journal of Cancer|October 29, 2014
Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinomaA B Suttle, H A Ball, M Molimard, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamidesM Gerspacher, L La Vecchia, R Mah, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline typeA von Sprecher, M Gerspacher, A Beck, et al.
Cephalalgia : an International Journal of Headache|February 26, 2009
Depression, migraine with aura and migraine without aura: their familiality and interrelatednessH A Ball, Z Samaan, S Brewster, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Biochemistry|November 26, 1990
Metabolism of cysteinyl leukotrienes in monkey and manM Huber, J Müller, I Leier, et al.
British Journal of Cancer|October 29, 2014
Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinomaA B Suttle, H A Ball, M Molimard, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamidesM Gerspacher, L La Vecchia, R Mah, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline typeA von Sprecher, M Gerspacher, A Beck, et al.
Cephalalgia : an International Journal of Headache|February 26, 2009
Depression, migraine with aura and migraine without aura: their familiality and interrelatednessH A Ball, Z Samaan, S Brewster, et al.
Pageof 3